Correlation Between 23Andme Holding and Accelerate Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Accelerate Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Accelerate Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Accelerate Diagnostics, you can compare the effects of market volatilities on 23Andme Holding and Accelerate Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Accelerate Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Accelerate Diagnostics.

Diversification Opportunities for 23Andme Holding and Accelerate Diagnostics

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between 23Andme and Accelerate is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Accelerate Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accelerate Diagnostics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Accelerate Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accelerate Diagnostics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Accelerate Diagnostics go up and down completely randomly.

Pair Corralation between 23Andme Holding and Accelerate Diagnostics

Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Accelerate Diagnostics. In addition to that, 23Andme Holding is 2.51 times more volatile than Accelerate Diagnostics. It trades about -0.19 of its total potential returns per unit of risk. Accelerate Diagnostics is currently generating about -0.19 per unit of volatility. If you would invest  188.00  in Accelerate Diagnostics on August 28, 2024 and sell it today you would lose (24.00) from holding Accelerate Diagnostics or give up 12.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

23Andme Holding Co  vs.  Accelerate Diagnostics

 Performance 
       Timeline  
23Andme Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Accelerate Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Accelerate Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

23Andme Holding and Accelerate Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 23Andme Holding and Accelerate Diagnostics

The main advantage of trading using opposite 23Andme Holding and Accelerate Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Accelerate Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accelerate Diagnostics will offset losses from the drop in Accelerate Diagnostics' long position.
The idea behind 23Andme Holding Co and Accelerate Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
CEOs Directory
Screen CEOs from public companies around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years